4//SEC Filing
Wood Gavin 4
Accession 0001104659-21-003134
CIK 0001621227other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 9:03 PM ET
Size
8.6 KB
Accession
0001104659-21-003134
Insider Transaction Report
Form 4
Wood Gavin
Chief Financial Officer
Transactions
- Award
Option to purchase Ordinary Shares
2021-01-11+242,712→ 242,712 totalExercise: $0.00Exp: 2031-01-11→ Ordinary Shares (242,712 underlying) - Award
Option to purchase Ordinary Shares
2021-01-11+1,086,816→ 1,086,816 totalExercise: $1.03Exp: 2031-01-11→ Ordinary Shares (1,086,816 underlying)
Footnotes (4)
- [F1]The exercise price was converted from GBP0.76 based on an exchange rate of U.S.$ 1.358422 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F2]Exercisable as to 271,704 Ordinary Shares on January 11, 2022 and will be exercisable as to the remainder in monthly installments of 22,638 Ordinary Shares on the eleventh of each month from February 11, 2022 through December 11, 2024 and 22,782 Ordinary Shares on January 11, 2025.
- [F3]The exercise price was converted from GBP0.001, being the nominal value of an ordinary share, based on an exchange rate of U.S.$ 1.358422 to GBP1.00. The actual exercise price will be the pounds sterling amount.
- [F4]Exercisable as to 60,678 Ordinary Shares on January 11, 2022 and will be exercisable as to the remainder in annual installments of 60,678 Ordinary Shares on the eleventh of each January from January 11, 2023 through January 11, 2025.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001577539
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 9:03 PM ET
- Size
- 8.6 KB